$3.11
4.36% today
Nasdaq, Nov 26, 03:14 pm CET
ISIN
US05280R1005
Symbol
AUTL
Sector
Industry

Autolus Therapeutics plc Target price 2024 - Analyst rating & recommendation

Autolus Therapeutics plc Classifications & Recommendation:

Buy
100%

Autolus Therapeutics plc Price Target

Target Price $10.76
Price $2.98
Potential
Number of Estimates 10
10 Analysts have issued a price target Autolus Therapeutics plc 2025 . The average Autolus Therapeutics plc target price is $10.76. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 11 Analysts recommend Autolus Therapeutics plc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Autolus Therapeutics plc stock has an average upside potential 2025 of . Most analysts recommend the Autolus Therapeutics plc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 1.70 14.47
72.54% 751.31%
EBITDA Margin -11,085.88% -1,366.42%
328.32% 87.67%
Net Margin -18,784.94% -1,577.61%
178.31% 91.60%

10 Analysts have issued a sales forecast Autolus Therapeutics plc 2024 . The average Autolus Therapeutics plc sales estimate is

$14.5m
Unlock
. This is
43.43% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$50.0m 395.54%
Unlock
, the lowest is
$2.3m 76.91%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $1.7m 72.54%
2024
$14.5m 751.31%
Unlock
2025
$72.5m 400.99%
Unlock
2026
$173m 138.87%
Unlock
2027
$377m 117.77%
Unlock
2028
$527m 39.79%
Unlock

6 Analysts have issued an Autolus Therapeutics plc EBITDA forecast 2024. The average Autolus Therapeutics plc EBITDA estimate is

$-198m
Unlock
. This is
0.33% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-112m 43.35%
Unlock
, the lowest is
$-236m 18.93%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-188m 17.63%
2024
$-198m 4.93%
Unlock
2025
$-187m 5.43%
Unlock
2026
$-124m 33.64%
Unlock
2027
$4.8m 103.84%
Unlock
2028
$162m 3,290.87%
Unlock

EBITDA Margin

2023 -11,085.88% 328.32%
2024
-1,366.42% 87.67%
Unlock
2025
-257.93% 81.12%
Unlock
2026
-71.66% 72.22%
Unlock
2027
1.26% 101.76%
Unlock
2028
30.64% 2,331.75%
Unlock

5 Autolus Therapeutics plc Analysts have issued a net profit forecast 2024. The average Autolus Therapeutics plc net profit estimate is

$-228m
Unlock
. This is
29.10% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-181m 43.82%
Unlock
, the lowest is
$-274m 14.89%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-319m 23.57%
2024
$-228m 28.51%
Unlock
2025
$-199m 12.91%
Unlock
2026
$-111m 44.41%
Unlock
2027
$9.1m 108.25%
Unlock
2028
$135m 1,385.20%
Unlock

Net Margin

2023 -18,784.94% 178.31%
2024
-1,577.61% 91.60%
Unlock
2025
-274.24% 82.62%
Unlock
2026
-63.81% 76.73%
Unlock
2027
2.42% 103.79%
Unlock
2028
25.69% 961.57%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -1.20 -0.86
23.57% 28.33%
P/E negative
EV/Sales 30.10

5 Analysts have issued a Autolus Therapeutics plc forecast for earnings per share. The average Autolus Therapeutics plc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.86
Unlock
. This is
28.93% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.68 43.80%
Unlock
, the lowest is
$-1.03 14.88%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.20 23.57%
2024
$-0.86 28.33%
Unlock
2025
$-0.75 12.79%
Unlock
2026
$-0.42 44.00%
Unlock
2027
$0.03 107.14%
Unlock
2028
$0.51 1,600.00%
Unlock

P/E ratio

Current -2.47 49.39%
2024
-3.47 40.49%
Unlock
2025
-3.99 14.99%
Unlock
2026
-7.18 79.95%
Unlock
2027
87.00 1,311.70%
Unlock
2028
5.85 93.28%
Unlock

Based on analysts' sales estimates for 2024, the Autolus Therapeutics plc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

30.10
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
54.80
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 43.18 62.20%
2024
30.10 30.28%
Unlock
2025
6.01 80.04%
Unlock
2026
2.52 58.14%
Unlock
2027
1.16 54.08%
Unlock
2028
0.83 28.47%
Unlock

P/S ratio

Current 78.60 48.04%
2024
54.80 30.28%
Unlock
2025
10.94 80.04%
Unlock
2026
4.58 58.14%
Unlock
2027
2.10 54.08%
Unlock
2028
1.50 28.46%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today